|
*Market share is calculated based on total revenue.
Publicly Traded Peers of Qrons Inc
Sage Therapeutics Inc
Share Performance
-73.15%
One Year
|
Sage Therapeutics Inc
Profile
Sage Therapeutics Inc's business model primarily revolves around researching, developing, and commercializing innovative therapies for various central nervous system disorders. The company focuses on discovering novel molecules and applying them to create targeted treatments that address the unmet medical needs of patients. By harnessing scientific advancements and strategic collaborations, Sage aims to deliver transformative therapies for individuals suffering from conditions such as depression, postpartum depression, and other mood disorders.
More about Sage Therapeutics Inc 's Market Share
|
Amgen Inc
Share Performance
-8.34%
This Year
|
Amgen Inc
Profile
Amgen Inc.s business model focuses on leveraging advanced biotechnology to create therapeutic products for various diseases, particularly in the fields of oncology, inflammation, and cardiovascular health. The company invests heavily in research and development to drive innovation, while also utilizing strategic partnerships and acquisitions to enhance its product pipeline. Additionally, Amgen emphasizes a strong global commercial presence to maximize the accessibility and impact of its therapeutics in the healthcare market.
More about Amgen Inc 's Market Share
|
Biogen Inc
Share Performance
-34.02%
One Year
|
Biogen Inc
Profile
Biogen Incs business model focuses on researching, developing, and commercializing innovative therapies primarily for neurological and neurodegenerative diseases, emphasizing advancements in precision medicine and patient care.
More about Biogen Inc 's Market Share
|
Coherus Biosciences inc
Share Performance
0.00%
Over The Past 5 Days
|
Coherus Biosciences inc
Profile
Coherus Biosciences Inc is a biopharmaceutical company focused on developing and commercializing high-quality biosimilar therapeutics. Their business model revolves around leveraging their expertise in cell culture, protein purification, formulation development, and analytical methods to manufacture and market biosimilar products. By providing cost-effective alternatives to expensive biologic drugs, Coherus Biosciences aims to make healthcare more accessible and affordable for patients.
More about Coherus Biosciences inc 's Market Share
|
Halozyme Therapeutics Inc
Share Performance
+20.55%
One Year
|
Halozyme Therapeutics Inc
Profile
Halozyme Therapeutics Inc is a biotechnology company that primarily focuses on developing and commercializing novel oncology therapies. Their business model involves leveraging their proprietary enzyme technology to improve the delivery and effectiveness of therapeutic drugs. By partnering with pharmaceutical companies, Halozyme aims to license their technology and collaborate on the development and commercialization of innovative therapies for various diseases.
More about Halozyme Therapeutics Inc 's Market Share
|
Exelixis Inc
Share Performance
+49.69%
This Year
|
Exelixis Inc
Profile
Exelixis Inc's business model is focused on the discovery, development, and commercialization of innovative therapies for the treatment of cancer.
More about Exelixis Inc 's Market Share
|
Denali Therapeutics Inc
Share Performance
0.00%
Over The Past 5 Days
|
Denali Therapeutics Inc
Profile
Denali Therapeutics Inc is a biotechnology company focused on developing and delivering effective therapies for neurodegenerative diseases. Their business model revolves around leveraging their deep knowledge of neurology and genetics to discover and develop innovative drugs. They aim to commercialize these therapies through strategic partnerships with pharmaceutical companies or through independent clinical development.
More about Denali Therapeutics Inc 's Market Share
|
Neumora Therapeutics Inc
Share Performance
-17.97%
One Year
|
Neumora Therapeutics Inc
Profile
Neumora Therapeutics Inc's business model focuses on developing and commercializing novel therapeutic solutions in the healthcare industry.
More about Neumora Therapeutics Inc 's Market Share
|
Vigil Neuroscience Inc
Share Performance
-38.03%
This Quarter
|
Vigil Neuroscience Inc
Profile
Vigil Neuroscience Inc's business model revolves around utilizing neuroscience to develop innovative solutions and technologies for various industries.
More about Vigil Neuroscience Inc 's Market Share
|
Neurocrine Biosciences Inc
Share Performance
-16.00%
This Quarter
|
Neurocrine Biosciences Inc
Profile
Neurocrine Biosciences Inc's business model involves researching, developing, and commercializing innovative therapies for neurological and endocrine disorders.
More about Neurocrine Biosciences Inc 's Market Share
|
Anavex Life Sciences Corp
Share Performance
+49.46%
This Year
|
Anavex Life Sciences Corp
Profile
Anavex Life Sciences Corp's business model focuses on the development and commercialization of innovative pharmaceutical products for the treatment of central nervous system diseases.
More about Anavex Life Sciences Corp 's Market Share
|
Recursion Pharmaceuticals Inc
Share Performance
+6.23%
One Year
|
Recursion Pharmaceuticals Inc
Profile
Recursion Pharmaceuticals Inc is a biotech company that utilizes its artificial intelligence (AI) platform to identify and develop potential drug candidates. They employ a unique approach by combining AI technology with experimental biology and automation to accelerate drug discovery. Recursion applies its platform to identify new treatments for rare diseases and have established partnerships with various organizations in the pharmaceutical industry.
More about Recursion Pharmaceuticals Inc 's Market Share
|
Athira Pharma Inc
Share Performance
-80.89%
This Quarter
|
Athira Pharma Inc
Profile
Athira Pharma Inc. is a biopharmaceutical company that aims to develop novel therapies for neurodegenerative diseases. Their business model focuses on discovering and developing small molecules and antibody drugs that target certain pathological mechanisms associated with these diseases.
More about Athira Pharma Inc 's Market Share
|
Voyager Therapeutics Inc
Share Performance
+1.74%
This Quarter
|
Voyager Therapeutics Inc
Profile
Voyager Therapeutics Inc. is a biopharmaceutical company that focuses on the development of gene therapies to treat severe neurological diseases. Their business model revolves around research, development, and commercialization of innovative treatments using viral gene therapy technology.
More about Voyager Therapeutics Inc 's Market Share
|
Aceragen Inc
Share Performance
-61.23%
30 Days
|
Aceragen Inc
Profile
Aceragen Inc is a biotechnology company that follows a business model focused on the research, development, and commercialization of innovative gene-based therapies for treating genetic diseases. They aim to leverage their expertise in genetic medicine to create and deliver advanced therapies that address unmet medical needs and improve patient outcomes.
More about Aceragen Inc 's Market Share
|
Ladrx Corporation
Share Performance
-64.74%
30 Days
|
Ladrx Corporation
Profile
Ladrx Corporation operates as a global technology solutions provider, offering a range of products and services in various industries. Their business model revolves around leveraging innovative technologies to develop tailored solutions for their clients, with a focus on enhancing operational efficiency and driving digital transformation. By combining their expertise in multiple domains and maintaining strong partnerships, Ladrx aims to deliver value-driven solutions to meet the evolving needs of businesses worldwide.
More about Ladrx Corporation's Market Share
|
Zura Bio Limited
Share Performance
-23.61%
This Quarter
|
Zura Bio Limited
Profile
Zura Bio Limited operates on a business model focused on developing and commercializing innovative bio-based solutions.
More about Zura Bio Limited's Market Share
|
Gilead Sciences Inc
Share Performance
+18.04%
One Year
|
Gilead Sciences Inc
Profile
Gilead Sciences Incs business model centers on researching, developing, and marketing innovative medicines, primarily targeting antiviral therapies. They focus on addressing unmet medical needs to enhance patient health globally.
More about Gilead Sciences Inc 's Market Share
|
Sources: Qrons Inc and all companies mentioned above in this report
|
